Familial myeloproliferative disease

Bailliere's Clinical Haematology

Volumn 11, Issue 4, 1998, Pages 849-858

  Gilbert, H S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Essential thrombocythaemia; Familial myeloproliferative disease; Myeloid metaplasia; Polycythaemia vera

Indexed keywords

ADULT; AGED; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; INHERITANCE; INTERNET; MALE; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PHENOTYPE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVIEW; STEM CELL; THROMBOCYTHEMIA;

EID: 0032322858     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(98)80042-5     Document Type: Article

References (22)

1. Adamson JW Familial polycythemia Seminars in Hematology 12 1975 383 396
2. Berk PD Goldberg JD Donovan PB Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols Seminars in Hematology 23 1986 132 143
3. Brubaker LH Wasserman LR Goldberg JD Increased prevalence of polycythemia vera in parents of patients on Polycythemia Vera Study Group protocols American Journal of Hematology 16 1984 367 373
4. Emanuel PD Eaves CJ Broudy VC Familial and congenital polychthemia in three unrelated families Blood 79 1992 3019 3030
5. Eyster ME Saletan SL Rabellino EM Familial essential thrombocythemia American Journal of Medicine 80 1986 497 502
6. Friedland ML Wittels EG Robinson RL Polycythemia vera in identical twins American Journal of Hematology 10 1981 101 107
7. Gilbert HS Familial Myeloproliferative Disease Wasserman LR Berk PD Berlin NI Polycythemia Vera and the Myeloproliferative Disorders 1995 WB Saunders Philadelphia 222 225
8. Gilbert HS Diagnosis and treatment of polycythemia vera, agnogenic myeloid metaplasia, and essential thrombocythemia Wiernik PH Canellos GP Kyle RA Schiffer CA Neoplastic Diseases of the Blood 1991 Churchill Livingstone New York 123 136
9. Gilbert HS Long term treatment of myeloproliferative disease with interferon-α-2b: feasibility and efficacy Cancer 83 1998 1205 1213
10. Levine AJ The p53 tumor suppressor gene New England Journal of Medicine 326 1992 1350 1352
11. Li FP Genetic and familial cancer: opportunities for prevention and early detection Cancer Detection and Prevention 9 1986 41 45
12. Malkin D Li FP Strong LC Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1990 1233 1238
13. Manorahan A Garson OM Familial polycythemia vera: a study of 3 sisters Scandinavian Journal of Haematology 17 1976 10 16
14. Miller RL Purvis JD 3rd Weick JK Familial polycythemia vera Cleveland Clinic Journal of Medicine 56 1989 813 818
15. Modan B Polycythemia: a review of epidemiological and clinical aspects Journal of Chronic Disease 18 1965 605 645
16. Perez-Encinas M Bello JL Perez-Crespo S Familial myeloproliferative syndrome American Journal of Hematology 46 1994 225 229
17. Pitcher L Taylor K Nichol J Thrombopoietin measurement in thrombocytosis: dysregulation and lack of feedback inhibition in essential thrombocythaemia British Journal of Haematology 99 1997 929 932
18. Randi ML Fabris F Visentin I Girolami A Low incidence of familial occurrence of thrombocythaemia and/or thrombocytosis Folia Haematologica 115 1988 695 699
19. Ratnoff WD Gress RE The familial occurrence of polycythemia vera: report of a father and son, with consideration of the possible etiologic role of exposure to organic solvents, including tetrachloroethlene Blood 56 1980 223 226
20. Shpilberg O Modan M Modan B Familial aggregation of haematological neoplasms: a controlled study British Journal of Haematology 87 1994 75 80
21. Slee PH van Everdingen JJ Geraedts JP Familial myeloproliferative disease. Hematological and cytogenetic studies Acta Medica Scandinavica 210 1981 321 327
22. Wiestner A Skoda RC van der Maas AP Schlemper RJ An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia Nature Genetics 18 1998 49 52